歡迎來到上海通蔚！

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 其他抗體 > RETNLB抗原（重組蛋白）

產(chǎn)品中心

  • RETNLB抗原（重組蛋白）

    規(guī)格：
    數(shù)量：

    購買數(shù)量

    價格：￥
    • 品牌 : 通蔚生物
    • 目錄號 : TW17145
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存：40
  • 商品詳情
  • 參考文獻
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品
中文名稱： RETNLB抗原（重組蛋白）

英文名稱： RETNLB Antigen (Recombinant Protein)

別       名： XCP2; FIZZ1; FIZZ2; HXCP2; RELMb; RELMbeta; RELM-beta

儲       存： 冷凍（-20℃）

相關(guān)類別： 抗原

概述

Fusion protein corresponding to a region derived from 24-111 amino acids of human RETNLB

技術(shù)規(guī)格

ull name:

resistin like beta

Synonyms:

XCP2; FIZZ1; FIZZ2; HXCP2; RELMb; RELMbeta; RELM-beta

Swissprot:

Q9BQ08

Gene Accession:

BC113502

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

Resistin-like beta is a protein that in humans is encoded by the RETNLB gene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.